glp-1 equivalency chart glp 1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art Comparison between GLP-1 receptor agonists

| Hyperhidrosis is not about being hot or nervous

Matrine treatment significantly reduced GPX4 protein levels while increasing lipid peroxidation and intracellular Fe 2+ content, indicating that matrine induces ferroptosis

Many patients notice increased energy and improved mental clarity within 24-48 hours of their first injection

The mean year 1 height velocity at a dosage of no more than 60 mcg/kg SC twice daily was 6.0 cm per year (95% confidence interval [CI], 5.1 to 6.9) compared with 8.5 cm per year (95% CI, 7.8 to 9.1) at a dosage of 120 mcg/kg SC twice daily

A large real-world study published in 2026 in the journal Inflammatory Bowel Diseases found that GLP-1 use in people with UC and Crohns disease was linked to lower rates of steroid use, hospitalization, and intestinal surgery